FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:446 August 8, 2002 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kantarjian, H. PubMed Citation

To the Editor: The impressive effects of the tyrosine kinase inhibitor STI571 (imatinib mesylate) in chronic myeloid leukemia were confirmed in the large trial by Kantarjian et al. (Feb. 28 issue).¹ We would like to report a new side effect of the drug.

Between December 1999 and June 2001, we treated 133 patients with chronic myeloid leukemia with imatinib mesylate according to Novartis Pharma protocols.^1,2 Among these 133 patients, 5 men and 4 women (median age, 63.4 years; range, 53 to 75) with gray hair before treatment had progressive repigmentation of the hair (on the head in 8 patients and . . . [Full Text of this Article]

This article has been cited by other articles:

• Hofer, A. C., Tran, R. T., Aziz, O. Z., Wright, W., Novelli, G., Shay, J., Lewis, M. (2005). Shared Phenotypes Among Segmental Progeroid Syndromes Suggest Underlying Pathways of Aging. J. Gerontol. A Biol. Sci. Med. Sci. 60: 10-20 [Abstract] [Full Text]  
• Guilhot, F. (2004). Indications for Imatinib Mesylate Therapy and Clinical Management. The Oncologist 9: 271-281 [Abstract] [Full Text]  
• Smith, K. J., Jacobson, E., Hamza, S., Skelton, H. (2004). Unexplained Hypereosinophilia and the Need for Cytogenetic and Molecular Genetic Analyses. Arch Dermatol 140: 584-588 [Abstract] [Full Text]  
• Moss, K. G., Toner, G. C., Cherrington, J. M., Mendel, D. B., Laird, A. D. (2003). Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans. J. Pharmacol. Exp. Ther. 307: 476-480 [Abstract] [Full Text]